IFI16 and cancer: Although we cannot fully conclude the mechanisms of IFI16 upregulation by gemcitabine treatment, it is postulated that gemcitabine, as a DNA damage agent, may cause the breakdown of dsDNA in both normal and cancer cells in the tumors (Jones et al., 2014).